169 related articles for article (PubMed ID: 38617839)
1. TOB1 modulates neutrophil phenotypes to influence gastric cancer progression and immunotherapy efficacy.
Zhang J; Li Y; Chen J; Huang T; Lin J; Pi Y; Hao H; Wang D; Liang X; Fu S; Yu J
Front Immunol; 2024; 15():1369087. PubMed ID: 38617839
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
Zhang SQ; Sun KK; Wu XY; Zhong N; Zhao H; Li DC
Mol Med Rep; 2015 Jul; 12(1):1177-82. PubMed ID: 25760308
[TBL] [Abstract][Full Text] [Related]
3. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.
Kundu J; Wahab SM; Kundu JK; Choi YL; Erkin OC; Lee HS; Park SG; Shin YK
Int J Oncol; 2012 Sep; 41(3):839-48. PubMed ID: 22710759
[TBL] [Abstract][Full Text] [Related]
4. The Overexpression of TOB1 Induces Autophagy in Gastric Cancer Cells by Secreting Exosomes.
Wang Y; Song Y; Zhou L; Wang M; Wang D; Bai J; Fu S; Yu J
Dis Markers; 2022; 2022():7925097. PubMed ID: 35465266
[TBL] [Abstract][Full Text] [Related]
5. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L
BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317
[TBL] [Abstract][Full Text] [Related]
6. Involvement of TOB1 on autophagy in gastric cancer AGS cells
Wang D; Li Y; Sui S; Cai M; Dong K; Wang P; Liang X; Fu S; Yu J
PeerJ; 2022; 10():e12904. PubMed ID: 35186488
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.
Guo H; Zhang R; Afrifa J; Wang Y; Yu J
Pathol Res Pract; 2019 Jun; 215(6):152403. PubMed ID: 30962003
[TBL] [Abstract][Full Text] [Related]
8. Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).
Jiao Y; Sun KK; Zhao L; Xu JY; Wang LL; Fan SJ
Acta Pharmacol Sin; 2012 Feb; 33(2):250-60. PubMed ID: 22158108
[TBL] [Abstract][Full Text] [Related]
9. TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer.
Bai Y; Qiao L; Xie N; Li Y; Nie Y; Pan Y; Shi Y; Wang J; Liu N
Cancer Med; 2020 Feb; 9(4):1503-1514. PubMed ID: 31891232
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-371a-3p promotes progression of gastric cancer by targeting TOB1.
Guo H; Ji F; Zhao X; Yang X; He J; Huang L; Zhang Y
Cancer Lett; 2019 Feb; 443():179-188. PubMed ID: 30529155
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
Li BS; Zuo QF; Zhao YL; Xiao B; Zhuang Y; Mao XH; Wu C; Yang SM; Zeng H; Zou QM; Guo G
Oncogene; 2015 May; 34(20):2556-65. PubMed ID: 25043310
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
Jiang K; Zhi XH; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of TOB1 at T172 and S320 is critical for gastric cancer proliferation and progression.
Wang D; Song H; Zhao T; Wang M; Wang Y; Yu L; Wang P; Yu J
Am J Transl Res; 2019; 11(8):5227-5239. PubMed ID: 31497236
[TBL] [Abstract][Full Text] [Related]
15. Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma.
Dong Z; Zhang G; Lu J; Guo Y; Liang J; Shen S; Guo W
Dig Dis Sci; 2023 Apr; 68(4):1316-1331. PubMed ID: 36002674
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions.
Yu J; Liu P; Cui X; Sui Y; Ji G; Guan R; Sun D; Ji W; Liu F; Liu A; Zhao Y; Yu Y; Jin Y; Bai J; Geng J; Xue Y; Qi J; Lee KY; Fu S
Mol Cells; 2011 Jul; 32(1):47-55. PubMed ID: 21533545
[TBL] [Abstract][Full Text] [Related]
17. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
[TBL] [Abstract][Full Text] [Related]
19. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of transducer of ErbB2.1 (TOB1) expression in patients with gastric cancer: tissue microarray analysis.
Yang Y; Shen X; Sun K
Int J Clin Exp Pathol; 2018; 11(8):4060-4066. PubMed ID: 31949796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
